This Nov 2017 report on Digital Health examines trends in three areas — innovation, evidence and adoption — to assess whether these new tools are positioned to have a fundamental impact on patient care specific to the U.K. healthcare system.
Very relevant to New Zealand as well, as we begin to see more interest in apps for mental health and wellbeing, self-monitoring, rehabilitation, and remote patient monitoring.The growing value of digital health in the UK.pdf (1.84 MB)
This report implies but doesn’t quite name a couple of critical things, in my opinion. They are, firstly that real strategic impact in digital health is more easily realised across a health system following a momentum or mandate created at a national level. Second, that the outcomes available through digital techs in health may need explicit new models to measure their impact and value, as current KPIs may not be sufficient or relevant. We should be more open to recognising when such outcomes arise outside of legacy KPIs.
I think if the value proposition is clear people will buy. Part of the problem is that the business model we most see is “here is something new/better which you can start/pay more for”.
In an industry which always has more “new/better” options than it can pay for it is hard to say yes to them all. I have some other thoughts/observations from my conversations with everyone which I will try to put together in a package for discussion
I am interested in that discussion. I agree too few R&D projects come with economics (hardly any). Healthcare providers are also shy of the data and capability within their own services to evaluate a value proposition, especially when the technology involves a disruption to the status quo.